Skip to content

Trueblue TBI Non-current Restricted Cash and Cash Equivalents

Non-current Restricted Cash and Cash Equivalents at other companies

Barrett Business Services logo
Barrett Business ServicesBBSI
$93.8M-13.4%
AMN Healthcare logo
AMN HealthcareAMN
$45.81M+1.7%

Other financials

Income statement

See full
Revenue$398.6M+7.6%
Gross profit$79.0M-8.5%
Operating income-$17.8M-26.4%
Net income-$19.8M-38.0%
EPS (diluted)-$0.66-37.5%

Balance sheet

See full
Cash & equivalents$24.1M+4.7%
Total debt$130.4M+13.2%
Total equity$256.1M-15.3%
Total assets$620.7M-10.4%

Cash flow

See full
Operating cash flow-$9.8M+55.8%
CapEx$2.8M-39.6%
Free cash flow-$12.6M+52.9%

Valuation

See full
Market cap$205.23M+4.8%
Enterprise value$311.53M+9.7%
P/S0.1×0.0×

Profitability

See full
Gross margin21.9%-3.7pp
Operating margin-3.1%-1.0pp
Net margin-3.2%-1.3pp
FCF margin-3.6%+0.8pp

Returns & leverage

See full
Return on equity-19.1%-6.2pp
Debt / equity0.5×+0.1×
Current ratio2.1×+0.3×

Where this comes from

Reported directly by Trueblue in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashAndInvestmentsNoncurrent.

The official record: Trueblue’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trueblue's non-current restricted cash and cash equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Trueblue's non-current restricted cash and cash equivalents?
Trueblue (TBI) reported non-current restricted cash and cash equivalents of $129.23M in Q1 2026.
How has Trueblue's non-current restricted cash and cash equivalents changed year-over-year?
Trueblue's non-current restricted cash and cash equivalents decreased by 24.1% year-over-year, from $170.21M to $129.23M.
What is the long-term trend for Trueblue's non-current restricted cash and cash equivalents?
Over 5 years (2020 to 2025), Trueblue's non-current restricted cash and cash equivalents has grown at a -10.7% compound annual growth rate (CAGR), from $240.53M to $136.59M.
What does non-current restricted cash and cash equivalents mean?
This represents cash and cash equivalents held in escrow or subject to legal or contractual restrictions that prevent their use for general operations for a period exceeding twelve months. Investors monitor this to understand liquidity constraints and the portion of capital tied up in long-term collateral or regulatory requirements.